Objective: The appropriate duration of antibiotic therapy for diabetic foot infections (DFI) after surgical amputations in toto is debated. There are discrepancies worldwide.
| Definitions and criteria
We used DFI definitions based on the IDSA guidelines criteria, which require clinical signs and symptoms of inflammation. 2 We included all DFI patients that were amputated or disarticulated in toto. Distal tibia and ankle amputations were included. We excluded amputations with no clinical signs of infection, regardless of microbiology results, 13 mid-tibia amputations, implant-related DFI and patients with <2 months of active follow-up. Osteomyelitis was diagnosed using clinical features (eg, visible bone), imaging (bone lesions without prior surgery or trauma 14 ) or microbiology (bacterial growth from surgically obtained bone specimens). We defined clinical failure as subsequent episodes of DFI occurring at the same location within 12 months. DFIs occurring later (ie, onset >12 months) were arbitrarily considered as new episodes. Microbiological failure was defined as recurrent DFI involving at least two of three pathogens from the index DFI recovered in deep tissue specimens. Remission was the absence of any clinical, laboratory or radiological evidence of failure at the end of follow-up. We considered antibiotics as broad-spectrum if piperacillin/tazobactam, glycopeptides, daptomycin, carbapenems or cefepime was used.
| Statistical analyses
We performed group comparisons using the Pearson chi-square test or the Wilcoxon rank-sum test. Cox regression analyses with cluster-control (random effect at patients' level) determined associations with failure. DFI episodes were censored at the last follow-up or occurrence of failure. We introduced independent variables having a P value ≤0.05 in the univariate analysis in a stepwise fashion in the multivariate model and checked for interaction (effect modification); antibiotic administration was automatically included into the final model. Age, total duration of antibiotic administration and duration of parenteral therapy were analysed both as continuous and categorical variables. The cut-off values of the strata were chosen according to the middle stratum positioned around the median value of that variable. We used Stata software (9.0, Stata™, College Station, TX, USA).
| RE SULTS

| Patients
We followed 482 DFI episodes involving amputation occurring in 258 different patients for a minimal duration of 2 months and a me- had any previous surgical procedure performed on their foot or ankle.
| Infections
The DFIs predominately affected the forefoot (n = 433; 90% ). Overall, 235 episodes (49%)
were polymicrobial. 
| Antibiotic administrations
Prior to admission or initial surgical procedure, 96 episodes (20%) already received systemic antibiotic therapy, 20 but exact data on duration or dosage are lacking. Following amputation, median duration of systemic antibiotic administration was 7 days (IQR, 1-16 days)
and median duration of parenteral use was 5 days (IQR, 0-12 days).
The entire antibiotic course was intravenous in 97 (20%) cases and oral in 69 cases (including perioperatively). In 109 cases (109/428; 25%), surgeons or physicians discontinued antibiotic administration immediately after amputation. The pathogens of these cases
were not special or different from DFIs with antibiotic continuation.
For example, P aeruginosa, 18 acknowledged as a major DFI pathogen leading to limb loss, 19 was as much present in DFIs with direct stop of post-amputation antibiotics as episodes with antimicrobial continuations (7/35 vs 102/551, P = 0.83). Overall, 128 different antimicrobial regimens were used, of which 144 (30%) included broad-spectrum antibiotics. The five most frequently used drugs were amoxicillin/clavulanate (n = 229), quinolones (n = 104; 18 cases as the only monotherapy), co-trimoxazole (n = 43), clindamycin (n = 32; five episodes as the sole monotherapy) and rifampicin in combination therapy (n = 25).
| Outcomes
Among 482 amputation stumps, clinical failure at the same anatomical site occurred in 90 cases (17%) within one year. However, only 38 were microbiological failures (ie, due to the same microorganisms; 38/482; 8%). There was at least partial concordance of the three dominant pathogens isolated from wound cultures between the initial and subsequent DFI episodes in only 42% of cases. Hence, the majority of subsequent DFI episodes (58%) were "clinical recurrences", rather than "microbiological recurrences" according to our definitions. Additionally, progressive ischaemia without clinical DFI occurred in 38 episodes (8%). At the end of the study, 86 patients had died for various reasons unrelated to acute DFI, even if eight of them were bacteremic (for another infection) during their hospital stay. Table 2 shows these results for the entire study population and separately for cases with osteomyelitis. 
| D ISCUSS I ON
This study of adult DFI patients from a defined clinical pathway
shows that the duration of antibiotic administration following radical amputation did not affect microbiological or clinical failure. This was equally true when interrupting antibiotic therapy immediately after wound closure and when analysing osteomyelitis cases alone.
Our study, with a total of 482 amputations in the infected diabetic foot, is to the best of our knowledge the largest existing single-cen- rather than from the removed bone. 30 Kowalski et al 21 demonstrated that amputated DFI patients with positive resection margins for residual osteomyelitis (histologically or microbiologically) revealed more treatment failures and re-amputations than those without (44% vs 15%, despite a similar 2 week intravenous antibiotic therapy in both arms). Atway et al reported a 41% incidence of positive bone resection margins among 27 trans-osseous amputations, compared to a 23% incidence following disarticulation.
29
Positive margins were associated with worse outcome despite a Besides the fact that our study is retrospective withloss or lack of data for certain variables, it has several limitations. Firstly, patients who were subsequently treated outside of our centre may have been lost to follow-up. However, our centre is the largest, and the only public, hospital in the region with a large catchment area. Indeed, patients seeking medical care consult mainly at our hospital, making this an unlikely major bias. Secondly, we did not analyse the antibiotic agents that were used, or the role of specific pathogens. This is based on the lack of evidence that any specific systemic antibiotic regimen is significantly superior for treatment of DFI, regardless of the involved pathogens. 1, 13, 15 Our study population and pathogens recovered were consistent with those reported in the literature. 1, 6 Moreover, antibiotic regimens often change throughout treatment course for these complex cases. In our study, 109 antibiotic regimens were changed during the course of therapy for a given infection episode. Likewise, we did not routinely assess residual stump osteomyelitis in patients undergoing atrial amputation. However, recent studies doubt about the accuracy of these specimens, 11 especially when they were sampled through the operation site. Thirdly, it is noteworthy that wound care, especially pressure offloading of the affected limb, is crucial for treating DFI. warranted.
TA B L E 1 Comparison of demographic, clinical and treatment characteristics of amputated patients with a single episode, versus those with subsequent episodes, of diabetic foot infection(s)
In conclusion, in our daily practice clinical pathway including 
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